Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products

Author： Bullano Michael F.   Al-Zakwani Ibrahim S.   Fisher Maxine D.   Menditto Laura   Willey Vincent J.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.2, 2005-02, pp. : 291-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir

By Peterson Gregory E.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2613-2619

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness and budget impact of long-acting risperidone in Portugal: a modeling exercise

By Heeg B. M. S.   Antunes J.   Figueira M. L.   Jara J. M.   Marques Teixeira J.   Palha A. P.   Vaz Serra A.   Buskens E.   Caleo S.   Gouveia-Pinto C.   Van Hout B. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 349-358

Informa Healthcare

Access to resources Recommend Favorite

Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension

By Bönner Gerd   Fuchs Winfried  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 935-940

Informa Healthcare

Access to resources Recommend Favorite

Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with Asthma

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite

Long‐Acting Reversible Contraception for Adolescents

By  

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 3, 2015-06 ,pp. : 253-259

John Wiley & Sons Inc

Access to resources Recommend Favorite